A new approach to vision restoration for inherited retinal diseases
Dr Michel Cayouette’s team (University of Montreal) has found a way to reactivate cells in the retina and turn them into light-sensing cells, potentially replacing those lost in retinal degeneration. This work,…
Jennifer Jones Joins Fighting Blindness Canada as New President and CEO
Tara James, Chair of the Board of Directors of Fighting Blindness Canada, is delighted to announce the appointment of Jennifer Jones as the new President and Chief Executive Officer (CEO) effective May…
Clinical Trial Advances for IRD, AMD and glaucoma
From April 23-27, Fighting Blindness Canada attended one of the largest vision research conferences in the world: the Association for Research in Vision and Ophthalmology (ARVO). It was illuminating to learn about…
Canadians now have access to Luxturna!
Luxturna is the first gene therapy treatment approved for an inherited retinal disease in Canada. The treatment is for people who have Leber congenital amaurosis (LCA) or retinitis pigmentosa (RP) caused by…
Welcome to View Point Calgary
Jump to: Welcome | Get Involved | Program | Speaker Bios | Exhibitors | Sponsors Welcome It gives us great pleasure to welcome you to View Point! At Fighting Blindness Canada, our…
Staff Spotlight: Susan Techner
We sat down with Fighting Blindness Canada’s Susan Techner, Senior Manager, Fundraising Events to learn about her and her dedication to fundraising for Fighting Blindness Canada. When did you start with the…
Join the Fight!
Learn how your support is helping to bring a future without blindness into focus! Be the first to learn about the latest breakthroughs in vision research and events in your community by subscribing to our e-newsletter that lands in inboxes the beginning of each month.
